Interpretation of the "Artificial intelligence to enhance precision medicine in cardio-oncology: A scientific statement from the American Heart Association"
- VernacularTitle:《人工智能增强肿瘤心脏病学精准医疗：美国心脏协会科学声明》解读
- Author:
Ying ZHANG
1
,
2
;
Xiaoyang LIAO
1
;
Hanfei YANG
3
;
Xi CHEN
4
;
Chuanying HUANG
5
;
Dongze LI
5
;
Yu JIA
1
;
Can SHEN
1
;
Yi LEI
1
;
Rong YANG
1
Author Information
1. General Practice Ward/International Medical Center Ward/Teaching & Research Section/General Practice Research Institute, General Practice Medical Center, West China Hospital, Sichuan University, Chengdu, 610041, P. R. China
2. West China School of Nursing, West China Hospital, Sichuan University, Chengdu, 610041, P. R. China
3. National Engineering Research Center for Cryptography Technology, Chengdu, 610041, P. R. China
4. Abdominal Oncology Department, West China Hospital, Sichuan University, Chengdu, 610041, P. R. China
5. Department of Emergency, West China Hospital, Sichuan University, Chengdu, 610041, P. R. China
- Publication Type:Journal Article
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2025;32(10):1360-1367
- CountryChina
- Language:Chinese
-
Abstract:
Cardiovascular disease and cancer are the two leading chronic conditions contributing to global mortality. With the rising incidence of cancer, the prevalence of cancer therapy-related cardiovascular complications has also increased, driving the development of the emerging field of cardio-oncology. The advancement of precision medicine offers new opportunities for the individualized and targeted management of cardiovascular toxicities associated with cancer treatment. Artificial intelligence (AI) has the potential to overcome traditional limitations in medical data integration, dynamic monitoring, and interdisciplinary collaboration, thereby accelerating the application of precision medicine in cardio-oncology. By enabling personalized treatment and reducing cardiovascular complications in cancer patients, AI serves as a critical tool in this domain. This article provides an in-depth interpretation of the 鈥淎rtificial intelligence to enhance precision medicine in cardio-oncology: a scientific statement from the American Heart Association鈥?aiming to inform the integration of AI into precision medicine in China. The goal is to promote its application in the management of cardiovascular diseases related to cancer therapy and to achieve precision management in this context.
